Recessive Stargardt disease phenocopying hydroxychloroquine retinopathy

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 254, Issue 5, 2016, Pages 865-872

  Nõupuu, Kalev ^a,b   Lee, Winston ^a   Zernant, Jana ^a   Greenstein, Vivienne C ^a   Tsang, Stephen ^a,c   Allikmets, Rando ^a,c  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF TARTU   (Estonia)

^c Department of Medicine   (United States)

Author keywords

ABCA4; Hydroxychloroquine toxicity; Phenocopy; Stargardt disease

Indexed keywords

HYDROXYCHLOROQUINE; ABC TRANSPORTER; ABCA4 PROTEIN, HUMAN; ANTIMALARIAL AGENT;

ABCA4 GENE; ADULT; ARTICLE; AUTOFLUORESCENCE IMAGING; CASE STUDY; CHILD; CLINICAL ARTICLE; ELECTRORETINOGRAM; FEMALE; GENE; GENE MUTATION; GENETIC SCREENING; HUMAN; MALE; OBSERVATIONAL STUDY; OPHTHALMOSCOPY; PHENOTYPE; PRIORITY JOURNAL; RECESSIVE GENE; RETINA MACULOPATHY; RETINOPATHY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; STARGARDT DISEASE; CHEMICALLY INDUCED; ELECTRORETINOGRAPHY; GENETICS; HIGH THROUGHPUT SEQUENCING; MACULAR DEGENERATION; MIDDLE AGED; MUTATION; OPTICAL COHERENCE TOMOGRAPHY; RETINAL DISEASES; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; ANTIMALARIALS; ATP-BINDING CASSETTE TRANSPORTERS; CHILD; ELECTRORETINOGRAPHY; FEMALE; GENES, RECESSIVE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; HYDROXYCHLOROQUINE; MACULAR DEGENERATION; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; RETINAL DISEASES; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84940055938     PISSN: 0721832X     EISSN: 1435702X     Source Type: Journal    
DOI: 10.1007/s00417-015-3142-8     Document Type: Article

References (38)

1. Michaelides M, Hunt DM, Moore AT (2003) The genetics of inherited macular dystrophies. J Med Genet 40(9):641–650
2. Allikmets R, Singh N, Sun H, Shroyer NF, Hutchinson A, Chidambaram A, Gerrard B, Baird L, Stauffer D, Peiffer A, Rattner A, Smallwood P, Li Y, Anderson KL, Lewis RA, Nathans J, Leppert M, Dean M, Lupski JR (1997) A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet 15(3):236–246. doi:10.1038/ng0397-236
3. Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH (1999) Insights into the function of Rim protein in photoreceptors and etiology of Stargardt’s disease from the phenotype in abcr knockout mice. Cell 98(1):13–23. doi:10.1016/S0092-8674(00)80602-9
4. Quazi F, Molday RS (2014) ATP-binding cassette transporter ABCA4 and chemical isomerization protect photoreceptor cells from the toxic accumulation of excess 11-cis-retinal. Proc Natl Acad Sci U S A 111(13):5024–5029. doi:10.1073/pnas.1400780111
5. Fishman GA, Stone EM, Grover S, Derlacki DJ, Haines HL, Hockey RR (1999) Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol 117(4):504–510
6. Noupuu K, Lee W, Zernant J, Tsang SH, Allikmets R (2014) Structural and genetic assessment of the ABCA4-associated optical gap phenotype. Invest Ophthalmol Vis Sci. doi:10.1167/iovs.14-14674
7. Cella W, Greenstein VC, Zernant-Rajang J, Smith TR, Barile G, Allikmets R, Tsang SH (2009) G1961E mutant allele in the Stargardt disease gene ABCA4 causes bull’s eye maculopathy. Exp Eye Res 89(1):16–24. doi:10.1016/j.exer.2009.02.001
8. Lois N, Holder GE, Bunce C, Fitzke FW, Bird AC (2001) Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol 119(3):359–369
9. Fujinami K, Sergouniotis PI, Davidson AE, Wright G, Chana RK, Tsunoda K, Tsubota K, Egan CA, Robson AG, Moore AT, Holder GE, Michaelides M, Webster AR (2013) Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function. Am J Ophthalmol 156(3):487–501. doi:10.1016/j.ajo.2013.05.003, e481
10. Fishman GA (1976) Fundus flavimaculatus. A clinical classification. Arch Ophthalmol 94(12):2061–2067
11. Kanski JJBB (2011) Clinical ophthalmology. A systemic approach, 7th edn. Elsevier, Edinburg
12. Rodriguez-Padilla JA, Hedges TR 3rd, Monson B, Srinivasan V, Wojtkowski M, Reichel E, Duker JS, Schuman JS, Fujimoto JG (2007) High-speed ultra-high-resolution optical coherence tomography findings in hydroxychloroquine retinopathy. Arch Ophthalmol 125(6):775–780. doi:10.1001/archopht.125.6.775
13. Chen E, Brown DM, Benz MS, Fish RH, Wong TP, Kim RY, Major JC (2010) Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the “flying saucer” sign). Clin Ophthalmol 4:1151–1158. doi:10.2147/OPTH.S14257
14. Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of O (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118(2):415–422. doi:10.1016/j.ophtha.2010.11.017
15. Marmor MF (2012) Comparison of screening procedures in hydroxychloroquine toxicity. Arch Ophthalmol 130(4):461–469. doi:10.1001/archophthalmol.2011.371
16. Ascaso FJ, Rodriguez NA, San Miguel R, Huerva V (2013) The “flying saucer” sign on spectral domain optical coherence tomography in chloroquine retinopathy. Arthritis Rheum 65(9):2322. doi:10.1002/art.38063
17. Tailor R, Elaraoud I, Good P, Hope-Ross M, Scott RA (2012) A case of severe hydroxychloroquine-induced retinal toxicity in a patient with recent onset of renal impairment: a review of the literature on the use of hydroxychloroquine in renal impairment. Case Rep Ophthalmol Med 2012:182747. doi:10.1155/2012/182747
18. Marmor MF, Fulton AB, Holder GE, Miyake Y, Brigell M, Bach M, International Society for Clinical Electrophysiology of V (2009) ISCEV Standard for full-field clinical electroretinography (2008 update). Doc Ophthalmol 118(1):69–77. doi:10.1007/s10633-008-9155-4
19. Zernant J, Schubert C, Im KM, Burke T, Brown CM, Fishman GA, Tsang SH, Gouras P, Dean M, Allikmets R (2011) Analysis of the ABCA4 gene by next-generation sequencing. Invest Ophthalmol Vis Sci 52(11):8479–8487. doi:10.1167/iovs.11-8182
20. van Huet RA, Bax NM, Westeneng-van Haaften SC, Muhamad M, Zonneveld-Vrieling MN, Hoefsloot LH, Cremers FP, Boon CJ, Klevering BJ, Hoyng C (2014) Foveal sparing in Stargardt disease. Invest Ophthalmol Vis Sci. doi:10.1167/iovs.13-13825
21. Sparrow JR, Boulton M (2005) RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res 80(5):595–606. doi:10.1016/j.exer.2005.01.007
22. Sparrow JR, Nakanishi K, Parish CA (2000) The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41(7):1981–1989
23. Kim SR, Nakanishi K, Itagaki Y, Sparrow JR (2006) Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res 82(5):828–839. doi:10.1016/j.exer.2005.10.004
24. Lee W, Noupuu K, Oll M, Duncker T, Burke T, Zernant J, Bearelly S, Tsang SH, Sparrow JR, Allikmets R (2014) The external limiting membrane in early-onset Stargardt disease. Invest Ophthalmol Vis Sci 55(10):6139–6149. doi:10.1167/iovs.14-15126
25. Wang JS, Kefalov VJ (2011) The cone-specific visual cycle. Prog Retin Eye Res 30(2):115–128. doi:10.1016/j.preteyeres.2010.11.001
26. Boon CJ, Jeroen Klevering B, Keunen JE, Hoyng CB, Theelen T (2008) Fundus autofluorescence imaging of retinal dystrophies. Vis Res 48(26):2569–2577. doi:10.1016/j.visres.2008.01.010
27. Schmitz-Valckenberg S, Fleckenstein M, Helb HM, Charbel Issa P, Scholl HP, Holz FG (2009) In vivo imaging of foveal sparing in geographic atrophy secondary to age-related macular degeneration. Invest Ophthalmol Vis Sci 50(8):3915–3921. doi:10.1167/iovs.08-2484
28. Bernstein H, Zvaifler N, Rubin M, Mansour AM (1963) The ocular deposition of chloroquine. Invest Ophthalmol 2:384–392
29. Sundelin SP, Terman A (2002) Different effects of chloroquine and hydroxychloroquine on lysosomal function in cultured retinal pigment epithelial cells. APMIS 110(6):481–489
30. Mahon GJ, Anderson HR, Gardiner TA, McFarlane S, Archer DB, Stitt AW (2004) Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy. Curr Eye Res 28(4):277–284
31. Burke TR, Duncker T, Woods RL, Greenberg JP, Zernant J, Tsang SH, Smith RT, Allikmets R, Sparrow JR, Delori FC (2014) Quantitative fundus autofluorescence in recessive Stargardt disease. Invest Ophthalmol Vis Sci 55(5):2841–2852. doi:10.1167/iovs.13-13624
32. Kellner U, Kellner S, Weinitz S (2008) Chloroquine retinopathy: lipofuscin- and melanin-related fundus autofluorescence, optical coherence tomography and multifocal electroretinography. Doc Ophthalmol 116(2):119–127. doi:10.1007/s10633-007-9105-6
33. Kellner U, Renner AB, Tillack H (2006) Fundus autofluorescence and mfERG for early detection of retinal alterations in patients using chloroquine/hydroxychloroquine. Invest Ophthalmol Vis Sci 47(8):3531–3538. doi:10.1167/iovs.05-1290
34. Kellner S, Weinitz S, Kellner U (2009) Spectral domain optical coherence tomography detects early stages of chloroquine retinopathy similar to multifocal electroretinography, fundus autofluorescence and near-infrared autofluorescence. Br J Ophthalmol 93(11):1444–1447. doi:10.1136/bjo.2008.157198
35. Gomes NL, Greenstein VC, Carlson JN, Tsang SH, Smith RT, Carr RE, Hood DC, Chang S (2009) A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci 50(8):3953–3959. doi:10.1167/iovs.08-2657
36. Burke TR, Rhee DW, Smith RT, Tsang SH, Allikmets R, Chang S, Lazow MA, Hood DC, Greenstein VC (2011) Quantification of peripapillary sparing and macular involvement in Stargardt disease (STGD1). Invest Ophthalmol Vis Sci 52(11):8006–8015. doi:10.1167/iovs.11-7693
37. Shroyer NF, Lewis RA, Lupski JR (2001) Analysis of the ABCR (ABCA4) gene in 4-aminoquinoline retinopathy: is retinal toxicity by chloroquine and hydroxychloroquine related to Stargardt disease? Am J Ophthalmol 131(6):761–766
38. Zernant J, Collison FT, Lee W, Fishman GA, Noupuu K, Yuan B, Cai C, Lupski JR, Yannuzzi LA, Tsang SH, Allikmets R (2014) Genetic and clinical analysis of ABCA4-associated disease in African American patients. Hum Mutat 35(10):1187–1194. doi:10.1002/humu.22626